Page last updated: 2024-12-07

s-(2-chloro-1,1,2-trifluoroethyl)cysteine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

S-(2-chloro-1,1,2-trifluoroethyl)cysteine: nephrotoxic cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID107692
MeSH IDM0137398

Synonyms (8)

Synonym
96563-01-8
s-(chloro-1,2,2-trifluoroethyl)-l-cysteine
s-(2-chloro-1,1,2-trifluoroethyl)-l-cysteine
l-cysteine, s-(2-chloro-1,1,2-trifluoroethyl)-
s-(2-chloro-1,1,2-trifluoroethyl)cysteine
ccris 1576
DTXSID00914456
goayamwhrinitl-ptlfgrinsa-n

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" DCVC was consistently found to be more toxic than DCVG, but the inclusion of gamma-glutamyltransferase (0."( Renal cysteine conjugate beta-lyase-mediated toxicity studied with primary cultures of human proximal tubular cells.
Chen, JC; Jones, TW; Stevens, JL; Trifillis, AL, 1990
)
0.28
" The efficient mitochondrial oxidation of hydrogen sulfide apparently serves to protect mitochondria against the toxic effects of hydrogen sulfide generated from CTFC."( Metabolism of S-(2-chloro-1,1,2-trifluoroethyl)-L-cysteine to hydrogen sulfide and the role of hydrogen sulfide in S-(2-chloro-1,1,2-trifluoroethyl)-L-cysteine-induced mitochondrial toxicity.
Anders, MW; Banki, K; Elfarra, AA; Lash, LH, 1986
)
0.27
" Moreover, S-(2-chloro-1,1,2-trifluoroethyl)-DL-alpha-methylcysteine, which cannot be metabolized by pyridoxal phosphate-dependent enzymes, was not toxic to isolated renal tubular cells."( Nephrotoxicity of S-(2-chloro-1,1,2-trifluoroethyl)glutathione and S-(2-chloro-1,1,2-trifluoroethyl)-L-cysteine, the glutathione and cysteine conjugates of chlorotrifluoroethene.
Anders, MW; Dohn, DR; Lash, LH; Leininger, JR; Quebbemann, AJ, 1985
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (25.00)18.7374
1990's6 (50.00)18.2507
2000's1 (8.33)29.6817
2010's0 (0.00)24.3611
2020's2 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.62

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.62 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.39 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.62)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (7.14%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (92.86%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]